Regular exercise is associated with better two-year outcomes in Parkinson's disease: National Parkinson foundation quality improvement initiative (NPF-QII) data

被引：0
|
作者：
Rafferty, M. R.
Schmidt, P. N.
Luo, S. T.
Li, K.
Cubillos, F.
Marras, C.
Davis, T.
Nelson, E. C.
Simuni, T.
机构：
来源：
MOVEMENT DISORDERS | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
480
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 33 条
  • [21] The profile of the hospitalized and re-hospitalized Parkinson's disease patient: 5 year data from the National Parkinson's Foundation
    Shahgholi, L.
    De Jesus, S.
    Wu, S.
    Pei, Q.
    Hassan, A.
    Schmidt, P.
    Okun, M.
    MOVEMENT DISORDERS, 2015, 30 : S121 - S121
  • [22] Two-year clinical outcomes associated with robotic-assisted subthalamic lead implantation in patients with Parkinson’s disease
    Michelle Paff
    Alice S. Wang
    Nicolas Phielipp
    Sumeet Vadera
    Anna Morenkova
    Neal Hermanowicz
    Frank P. K. Hsu
    Journal of Robotic Surgery, 2020, 14 : 559 - 565
  • [23] Two-year clinical outcomes associated with robotic-assisted subthalamic lead implantation in patients with Parkinson's disease
    Paff, Michelle
    Wang, Alice S.
    Phielipp, Nicolas
    Vadera, Sumeet
    Morenkova, Anna
    Hermanowicz, Neal
    Hsu, Frank P. K.
    JOURNAL OF ROBOTIC SURGERY, 2020, 14 (04) : 559 - 565
  • [24] Changes in Prescribing Practices of Dopaminergic Medications in Individuals with Parkinson's Disease by Expert Care Centers from 2010 to 2017: The Parkinson's Foundation Quality Improvement Initiative
    Dubaz, Ornella M.
    Wu, Samuel
    Cubillos, Fernando
    Miao, Guanhong
    Simuni, Tanya
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2019, 6 (08): : 687 - 692
  • [25] Two-Year Exercise Program Improves Physical Function in Parkinson's Disease: The PRET-PD Randomized Clinical Trial
    Prodoehl, Janey
    Rafferty, Miriam R.
    David, Fabian J.
    Poon, Cynthia
    Vaillancourt, David E.
    Comella, Cynthia L.
    Leurgans, Sue E.
    Kohrt, Wendy M.
    Corcos, Daniel M.
    Robichaud, Julie A.
    NEUROREHABILITATION AND NEURAL REPAIR, 2015, 29 (02) : 112 - 122
  • [26] Is hyperhomocysteinemia associated with the structural changes of the substantia nigra in Parkinson's disease? A two-year follow-up study
    Zhang, Guohua
    Zhang, Chengguo
    Wang, Yukai
    Wang, Lijuan
    Zhang, Yuhu
    Xie, Haiqun
    Lu, Jiancong
    Nie, Kun
    PARKINSONISM & RELATED DISORDERS, 2019, 60 : 46 - 50
  • [27] Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study (Publication with Expression of Concern)
    Minato, Tomomi
    Maeda, Tetsuya
    Fujisawa, Yoshiro
    Tsuji, Hirokazu
    Nomoto, Koji
    Ohno, Kinji
    Hirayama, Masaaki
    PLOS ONE, 2017, 12 (11):
  • [28] Two-year, placebo-controlled safety and tolerability data for safinamide as add-on to levodopa in patients with Parkinson's disease
    Meshram, C.
    Borgohain, R.
    Bhatt, M.
    Chirileanu, D.
    Stocchi, F.
    Lucini, V.
    Giuliani, R.
    Anand, R.
    MOVEMENT DISORDERS, 2011, 26 : S134 - S135
  • [29] TWO-YEAR, PLACEBO-CONTROLLED SAFETY AND TOLERABILITY DATA FOR SAFINAMIDE AS ADD-ON TO L-DOPA IN PATIENTS WITH PARKINSON'S DISEASE
    Meshram, C.
    Borgohain, R.
    Bhatt, M.
    Chirileanu, D.
    Stocchi, F.
    Lucini, V.
    Giuliani, R.
    Anand, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 232 - 233
  • [30] Improvement in Attention/Memory Domains in Advanced Parkinson's Disease Patients Treated with Levodopa-carbidopa Intestinal Gel is Associated with Better Quality of Life
    Standaert, David
    Rodriguez, Ramon
    Slevin, John
    Hall, Coleen
    Facheris, Maurizio
    Benesh, Janet
    Dubow, Stephanie
    NEUROLOGY, 2018, 90
1234